Prostate

Cedars-Sinai Cancer investigators have identified two promising new treatment options for men with recurrent prostate cancer -- both of which helped patients live longer without their…

“Me encontraron càncer en la pròstata,” my father told me. They found cancer in my prostate. As a cancer researcher who knows very well about the high incidence and decreased survival…

IRVINE, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (the “Company”) is pleased to announce today important new long-term clinical trial results from the…

Ann Schreiber In 2023 alone, 288,300 new cases of prostate cancer will be diagnosed in the United States, according to the American Cancer…

Magnetic resonance (MR)‐guided adaptive stereotactic body radiotherapy (SBRT)…

University of South Australia researchers have identified three new biomarkers for prostate cancer to help identify and differentiate potentially aggressive cases of the disease which kills…

SAN DIEGO, July 19, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., Ambrx (or the “Company”) (NASDAQ: AMAM), today announced that the U.S. Food and Drug Administration (FDA) has granted…

Prostate cancer is a leading cause of death among American men, and it's resistant to one of the most powerful chemotherapy medications -- cisplatin. Now, researchers reporting in ACS…

Wilmington, Delaware, United States, July 10, 2023 (GLOBE NEWSWIRE) -- The global prostate cancer therapeutics market is projected to expand at a CAGR of 6.9% from 2022 to 2031 to reach…

-- Prostate Circulating Tumor Cells Isolated with TellDx Technology Demonstrates Epigenetic Changes that Silence Immune Surveillance Genes and Spare Proliferation-Associated Genes -- --…